JYPC(SZ:002198) Zheng Quan Zhi Xing·2025-03-27 16:25Core Viewpoint - The legal opinion issued by Hunan Qiyuan Law Firm confirms the legality and validity of the procedures, participants, and voting results of the 2025 first extraordinary general meeting of shareholders of Guangdong Jiaying Pharmaceutical Co., Ltd [1][8]. Group 1: Meeting Procedures - The notice for the meeting was announced on the Shenzhen Stock Exchange website, detailing the time, location, method, agenda, and registration process [2]. - The meeting was held on March 27, 2025, at 14:30 in Meizhou, Guangdong Province [2][3]. - Voting was conducted through both a trading system and an internet voting platform on the same day [3]. Group 2: Participant Qualifications - A total of 2 shareholders attended the meeting in person, holding 11,700,192 shares, which is 2.3385% of the total voting shares [3][4]. - Additionally, 152 shareholders participated via internet voting, holding a total of 101,458,401 shares [5]. Group 3: Voting Procedures and Results - The meeting utilized a named voting method for the in-person session, with representatives appointed for counting votes [6]. - The combined voting results showed that 107,652,856 shares (95.1345%) were in favor of the proposals, with 47,127,166 shares (90.4070%) from minority investors [6][7]. - The voting results were consistent across multiple counts, confirming the legitimacy of the voting process [7]. Group 4: Conclusion - The legal opinion concludes that the meeting's procedures, participant qualifications, and voting results are all in compliance with relevant laws and regulations [8].